Year |
Citation |
Score |
2018 |
Yu X, Zhang Y, Cavazos D, Ma X, Zhao Z, Du L, Pertsemlidis A. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer. Cell Death & Disease. 9: 193. PMID 29416000 DOI: 10.1038/S41419-017-0219-9 |
0.304 |
|
2017 |
Brenner A, Lengfelder L, Quach D, Cavazos D, Ramirez R, Gruslova A, Kist K, Lathrup K, Kaklamani V, Beeram M, deGraffenried L. Abstract P1-09-16: Randomized study of COX2 inhibition on systemic inflammation in obese and non-obese subjects Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-09-16 |
0.376 |
|
2017 |
Khatib SA, Bowers LW, Rossi EL, McDonell SB, Lineberger CG, Cavazos DA, deGraffenried LA, Hursting SD. Abstract 1849: The role of leptin signaling in the promotion of obesity-associated tumorigenesis and cancer stem cell characteristics in a transgenic mouse model of basal-like breast cancer Cancer Research. 77: 1849-1849. DOI: 10.1158/1538-7445.Am2017-1849 |
0.444 |
|
2017 |
Patel V, Maknojia A, Garcia M, Cavazos D, Gruslova A, Courtney B, Papanikolaou N, Kidane D, Brenner A, Floyd J. Mngi-11. Treatment Of Meningioma With Th-302 In A Pdx Mouse Model And Cell Line Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.549 |
0.326 |
|
2016 |
Henry S, Kidner R, Reisenauer MR, Magedov IV, Kiss R, Mathieu V, Lefranc F, Dasari R, Evidente A, Yu X, Ma X, Pertsemlidis A, Cencic R, Pelletier J, Cavazos DA, et al. 5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells. European Journal of Medicinal Chemistry. 120: 313-328. PMID 27218860 DOI: 10.1016/J.Ejmech.2016.05.004 |
0.43 |
|
2016 |
Sareddy GR, Li X, Liu J, Viswanadhapalli S, Garcia L, Gruslova A, Cavazos D, Garcia M, Strom AM, Gustafsson JA, Tekmal RR, Brenner A, Vadlamudi RK. Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma. Scientific Reports. 6: 24185. PMID 27126081 DOI: 10.1038/Srep24185 |
0.405 |
|
2016 |
Faris R, Weber MM, Seeger DR, Cavazos D, de Graffenried L, Murphy EJ, Jolly CA. Mitochondrial Glycerol-3-Phosphate Acyltransferase-Dependent Phospholipid Synthesis Modulates Phospholipid Mass and IL-2 Production in Jurkat T Cells. Lipids. PMID 26797755 DOI: 10.1007/S11745-016-4121-5 |
0.306 |
|
2016 |
Cavazos D, Gruslova A, Garcia M, Brenner A. Abstract P5-05-03: Targeting hypoxia-induced cancer cell metabolism in breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-05-03 |
0.489 |
|
2015 |
Gruslova A, Cavazos DA, Miller JR, Breitbart E, Cohen YC, Bangio L, Yakov N, Soundararajan A, Floyd JR, Brenner AJ. VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme. Journal of Neuro-Oncology. PMID 26108658 DOI: 10.1007/S11060-015-1853-7 |
0.351 |
|
2015 |
Cavazos DA, Brenner AJ. Hypoxia in astrocytic tumors and implications for therapy. Neurobiology of Disease. PMID 26094595 DOI: 10.1016/J.Nbd.2015.06.007 |
0.301 |
|
2015 |
Aksenov AV, Smirnov AN, Magedov IV, Reisenauer MR, Aksenov NA, Aksenova IV, Pendleton AL, Nguyen G, Johnston RK, Rubin M, De Carvalho A, Kiss R, Mathieu V, Lefranc F, Correa J, ... Cavazos DA, et al. Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells. Journal of Medicinal Chemistry. 58: 2206-20. PMID 25671501 DOI: 10.1021/Jm501518Y |
0.428 |
|
2015 |
Cavazos DA, Wheatly K, Hursting S. Abstract A06: Obesity induces a metabolic switch toward aerobic glycolysis in breast cancer cells in vitro and in vivo Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-A06 |
0.408 |
|
2015 |
Sareddy GR, Gruslova A, Cavazos DA, Tekmal RR, Brenner AJ, Vadlamudi RK. Abstract 951: LY500307 as a novel therapeutic agent for treatment of glioblastoma Cancer Research. 75: 951-951. DOI: 10.1158/1538-7445.Am2015-951 |
0.462 |
|
2015 |
Cavazos D, Caflisch L, Gruslova A, Garcia M, Brenner A. Metb-03Targeting Cancer Cell Metabolism In Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov221.03 |
0.428 |
|
2015 |
Sareddy GR, Cavazos D, Gruslova A, Brenner A, Vadlamudi R. ATPS-76ESTROGEN RECEPTOR β AGONISTS: NOVEL THERAPEUTIC AGENTS FOR GLIOBLASTOMA Neuro-Oncology. 17: v35.1-v35. DOI: 10.1093/Neuonc/Nov204.76 |
0.389 |
|
2014 |
Cavazos DA, Degraffenried MJ, Apte SA, Bowers LW, Whelan KA, Degraffenried LA. Obesity promotes aerobic glycolysis in prostate cancer cells Nutrition and Cancer. 66: 1179-1186. PMID 25264717 DOI: 10.1080/01635581.2014.951738 |
0.413 |
|
2013 |
Bowers LW, Cavazos DA, Maximo IX, Brenner AJ, Hursting SD, deGraffenried LA. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression. Breast Cancer Research : Bcr. 15: R59. PMID 23880059 DOI: 10.1186/Bcr3453 |
0.421 |
|
2013 |
Apte SA, Cavazos DA, Whelan KA, Degraffenried LA. A low dietary ratio of omega-6 to omega-3 fatty acids may delay progression of prostate cancer Nutrition and Cancer. 65: 556-562. PMID 23659447 DOI: 10.1080/01635581.2013.775316 |
0.371 |
|
2013 |
De Angulo A, Faris R, Cavazos D, Jolly C, Daniel B, DeGraffenried L. Age-related alterations in T-lymphocytes modulate key pathways in prostate tumorigenesis. The Prostate. 73: 855-64. PMID 23532664 DOI: 10.1002/Pros.22631 |
0.35 |
|
2012 |
Siddiqa A, Cavazos D, Chavez J, Long L, Marciniak RA. Modulation of telomeres in alternative lengthening of telomeres type I like human cells by the expression of werner protein and telomerase. Journal of Oncology. 2012: 806382. PMID 22545052 DOI: 10.1155/2012/806382 |
0.681 |
|
2012 |
Price RS, Cavazos DA, De Angel RE, Hursting SD, deGraffenried LA. Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate Cancer and Prostatic Diseases. 15: 135-43. PMID 22333686 DOI: 10.1038/Pcan.2011.54 |
0.389 |
|
2012 |
Alejandra DA, Faris R, Cavazos D, deGraffenried L, Jolly C. Abstract 3553: Modulation of pro-inflammatory signaling pathways by aging T-lymphocytes contributes to a more malignant phenotype in prostate epithelial cells Cancer Research. 72: 3553-3553. DOI: 10.1158/1538-7445.Am2012-3553 |
0.372 |
|
2012 |
Price RS, Cavazos D, deGraffenried LA. Abstract 1526: Obesity modulates the microenvironment promoting NF-κB activity in prostate cancer cells Cancer Research. 72: 1526-1526. DOI: 10.1158/1538-7445.Am2012-1526 |
0.433 |
|
2011 |
Cavazos DA, Price RS, Apte SS, deGraffenried LA. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. The Prostate. 71: 1420-8. PMID 21360560 DOI: 10.1002/Pros.21359 |
0.391 |
|
2011 |
Price RS, Cavazos DA, deGraffenried LA. Abstract 971: Obesity initiates a self-perpetuating inflammatory response in LNCaP prostate cancer cells Cancer Research. 71: 971-971. DOI: 10.1158/1538-7445.Am2011-971 |
0.391 |
|
2011 |
Angulo AD, Faris R, Cavazos D, Jolly C, deGraffenried LA. Abstract 5577: The role of age-related enhancements of IL-17 in prostate cancer initiation and progression Cancer Research. 71: 5577-5577. DOI: 10.1158/1538-7445.Am2011-5577 |
0.392 |
|
2011 |
Apte SA, Cavazos D, Hursting S, Nogueira L, deGraffenried LA. Abstract 5574: mTOR is a target for omega-3 fatty acid modulation of prostate cancer progression Cancer Research. 71: 5574-5574. DOI: 10.1158/1538-7445.Am2011-5574 |
0.448 |
|
2011 |
Bowers LW, Angel RD, Cavazos D, Hursting S, Brenner A, deGraffenried L. Abstract 531: Obesity-associated growth factor signaling upregulates aromatase expression in breast cancer cells Cancer Research. 71: 531-531. DOI: 10.1158/1538-7445.Am2011-531 |
0.423 |
|
2011 |
Whelan KA, Cavazos D, deGraffenried LA. Abstract 4213: Defining the role of NF-kB as a target for omega-3 fatty acids in prostate cancer Cancer Research. 71: 4213-4213. DOI: 10.1158/1538-7445.Am2011-4213 |
0.457 |
|
2011 |
Cavazos DA, deGraffenried LA. Abstract 4207: DHA enhances genotoxic stress in prostate cancer cells through suppression of NF-κB Cancer Research. 71: 4207-4207. DOI: 10.1158/1538-7445.Am2011-4207 |
0.438 |
|
2010 |
Cavazos DA, deGraffenried LA. Abstract 59: Impact of omega-3 fatty acids on obesity-induced DNA oxidation and prostate cancer progression Cancer Research. 70: 59-59. DOI: 10.1158/1538-7445.Am10-59 |
0.434 |
|
2010 |
Chen CH, Cavazos DA, Apte SA, Fabian C, Hursting S, deGraffenried LA. Abstract 5713: Omega-3 fatty acid molecular and cellular modulation of in vitro models of high-risk breast cancer Cancer Research. 70: 5713-5713. DOI: 10.1158/1538-7445.Am10-5713 |
0.453 |
|
2010 |
Salcedo R, Cavazos D, Hursting S, Angel RD, deGraffenried L, Beeram M. Abstract 5088: In vitro induction of a more aggressive prostate cancer phenotype by exposure to obese sera Cancer Research. 70: 5088-5088. DOI: 10.1158/1538-7445.Am10-5088 |
0.403 |
|
2010 |
Angulo AD, Jolly CA, Faris R, Cavazos D, Salcedo R, Apte S, Chen C, deGraffenried LA. Abstract 2472: The role of aging T-cells in prostate cancer development Cancer Research. 70: 2472-2472. DOI: 10.1158/1538-7445.Am10-2472 |
0.433 |
|
2010 |
Apte S, Friedrichs W, Hursting S, Cavazos D, Nogueira L, Perkins S, deGraffenried LA. Abstract 1873: Delayed progression to hormone-independent prostate cancer through modulation of mTOR by omega-3 fatty acids Cancer Research. 70: 1873-1873. DOI: 10.1158/1538-7445.Am10-1873 |
0.341 |
|
2010 |
Bowers L, Cavazos D, Angel RD, Price R, Hursting S, Brenner A, deGraffenried L. Abstract PD09-06: Obesity Promotes Breast Cancer Progression and Tamoxifen Resistance Via Cross-Talk between Growth Factor and Estrogen Signaling Pathways Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd09-06 |
0.41 |
|
2009 |
Chen C, Gasperi MD, Salcedo R, Cavazos D, deGraffenried L. Evaluation of the Phytochemical Anethole as an Anti-Tumor Agent in MCF-7 Cells. Cancer Research. 69: 3100-3100. DOI: 10.1158/0008-5472.Sabcs-09-3100 |
0.475 |
|
2009 |
Gasperi MD, Cavazos D, deGraffenried L. Curcumin Modulates Tamoxifen Response in Resistant Breast Cancer Cells. Cancer Research. 69: 3098-3098. DOI: 10.1158/0008-5472.Sabcs-09-3098 |
0.483 |
|
2007 |
Silva J, Cavazos DA, Donzis E, Friedrichs WE, Marciniak R, DeGraffenried LA. Akt-induced tamoxifen resistance is associated with altered FKHR regulation Cancer Investigation. 25: 569-573. PMID 17952739 DOI: 10.1080/07357900701513538 |
0.676 |
|
2006 |
Siddiqa A, Cavazos DA, Marciniak RA. Targeting telomerase. Rejuvenation Research. 9: 378-90. PMID 16859479 DOI: 10.1089/rej.2006.9.378 |
0.695 |
|
2006 |
Kazhdan I, Long L, Montellano R, Cavazos DA, Marciniak RA. Targeted gene therapy for breast cancer with truncated Bid. Cancer Gene Therapy. 13: 141-9. PMID 16110313 DOI: 10.1038/Sj.Cgt.7700867 |
0.69 |
|
2005 |
Marciniak RA, Cavazos D, Montellano R, Chen Q, Guarente L, Johnson FB. A novel telomere structure in a human alternative lengthening of telomeres cell line. Cancer Research. 65: 2730-7. PMID 15805272 DOI: 10.1158/0008-5472.Can-04-2888 |
0.677 |
|
Show low-probability matches. |